Lyonbiopole Diseases Center opened its doors on April 1st, 2009 at the Domilyon building in Lyon-Gerland (7th district). It is already full, hosting six research teams: Inserm U851, Inserm U851/Finovi, the Mérieux Institute, the PLATINE project (Innate-Pharma, Transgene, ImmunID, Inserm and the Léon Bérard Cancer Research Center), PX’Therapeutics and Transgene.
This platform, the only one of its kind in Europe, features 1,920 sq. m. of Biosafety Level 2 and 3 laboratories and shared facilities.